Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 521,000 |
50 mg | 約10-14 週間 | ¥ 684,000 |
100 mg | 約10-14 週間 | ¥ 918,000 |
説明 | PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor. |
別名 | PF 06439015, PF-06439015, PF06439015 |
分子量 | 470.52 |
分子式 | C22H23FN6O3S |
CAS No. | 1549629-82-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-06439015 mesylate 1549629-82-4 PF-06439015 Mesylate PF 06439015 PF-06439015 PF06439015 Mesylate PF06439015 mesylate PF 06439015 mesylate PF 06439015 Mesylate PF06439015 Inhibitor inhibitor inhibit